comparemela.com

Latest Breaking News On - Suspected prostate cancer recurrence - Page 4 : comparemela.com

U S FDA Approves Blue Earth Diagnostics POSLUMA (Flotufolastat F 18) Injection, First Radiohybrid PSMA-targeted PET Imaging Agent for Prostate Cancer

- POSLUMA will be commercially available in the United States in early June 2023 - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative

United kingdomUnited statesClare gidleyMike beyerPriscilla harlanShelby moneerDavidm schusterBrianf chapinScintomics gmbDavide gaudenTechnical university of munichNuclear medicineDrug administrationDepartment of urologyEmory university school of medicineCorporate communications

Blue Earth Diagnostics Highlights Upcoming Presentation of Key Results from Phase 3 SPOTLIGHT Study of Targeted PET Imaging Agent 18F-rhPSMA-7 3 in Biochemically Recurrent Prostate Cancer

Blue Earth Diagnostics Highlights Upcoming Presentation of Key Results from Phase 3 SPOTLIGHT Study of Targeted PET Imaging Agent 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer - read this article along with other careers information, tips and advice on BioSpace

United statesSan franciscoScintomics gmbDavidm schusterTechnical university of munichNuclear medicineWinship cancer institute of emory universityBlue earth diagnostic medical affairsBracco groupEarth diagnosticsCancers symposiumProstate specific membrane antigen targetedDetection ratesSuspected prostate cancer recurrenceMulticenter studyWinship cancer institute

Blue Earth Diagnostics Highlights Upcoming Presentation of Key Results from Phase 3 SPOTLIGHT Study of Targeted PET Imaging Agent 18F-rhPSMA-7 3 in Biochemically Recurrent Prostate Cancer

BURLINGTON, Mass. & OXFORD, England (BUSINESS WIRE) Feb 1, 2022

United statesUnited kingdomSan franciscoScintomics gmbGeorgina mowattDavidm schusterMike beyerPriscilla harlanWinship cancer institute of emory universitySam brown incBracco groupTechnical university of munichNuclear medicineCorporate communicationsBlue earth diagnostic medical affairsEarth diagnostics

vimarsana © 2020. All Rights Reserved.